Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Torsten Tonn

Showing results (21-30 of 138) with videos related to

Pageof 14
Sort By:
European Journal of Immunology|May 9, 2018
PRAME peptide-specific CD8<sup>+</sup> T cells represent the predominant response against leukemia-associated antigens in healthy individualsSarah Matko, Julia Manderla, Maria Bonsack, et al.
Cytometry. Part a : the Journal of the International Society for Analytical Cytology|May 26, 2017
Enumeration of WT1-specific CD8<sup>+</sup> T cells for clinical application using an MHC Streptamer based no-wash single-platform flow-cytometric assaySarah Matko, Madeleine Teichert, Antje Tunger, et al.
Immunology Letters|September 29, 2022
SARS-CoV-2-specicific humoral immunity in convalescent patients with mild COVID-19 is supported by CD4<sup>+</sup> T-cell help and negatively correlated with Alphacoronavirus-specific antibody titerMarcus Odendahl, Iris Endler, Beate Haubold, et al.
International Journal of Radiation Biology|November 10, 2009
Response of human hematopoietic stem and progenitor cells to energetic carbon ionsDaniela Becker, Thilo Elsässer, Torsten Tonn, et al.
Transfusion|September 21, 2007
Impact of leukapheresis on early death rate in adult acute myeloid leukemia presenting with hyperleukocytosisGesine Bug, Konstantinos Anargyrou, Torsten Tonn, et al.
Frontiers in Immunology|June 3, 2017
Chimeric Antigen Receptor-Engineered NK-92 Cells: An Off-the-Shelf Cellular Therapeutic for Targeted Elimination of Cancer Cells and Induction of Protective Antitumor ImmunityCongcong Zhang, Pranav Oberoi, Sarah Oelsner, et al.
Blood|August 1, 2002
Retargeting of natural killer-cell cytolytic activity to ErbB2-expressing cancer cells results in efficient and selective tumor cell destructionChristoph Uherek, Torsten Tonn, Barbara Uherek, et al.
Journal for Immunotherapy of Cancer|January 20, 2021
Inability of granule polarization by NK cells defines tumor resistance and can be overcome by CAR or ADCC mediated targetingJiri Eitler, Natalie Wotschel, Nicole Miller, et al.
Pediatric Transplantation|December 11, 2008
Intracoronary administration of autologous bone marrow-derived progenitor cells in a critically ill two-yr-old child with dilated cardiomyopathyStefan Rupp, Jürgen Bauer, Torsten Tonn, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|October 11, 2003
Sustained expansion and transgene expression of coagulation factor VIII-transduced cord blood-derived endothelial progenitor cellsChristian Herder, Torsten Tonn, Robert Oostendorp, et al.
Pageof 14

Showing results (21-30 of 138) with videos related to

Sort By:
Pageof 14
European Journal of Immunology|May 9, 2018
PRAME peptide-specific CD8<sup>+</sup> T cells represent the predominant response against leukemia-associated antigens in healthy individualsSarah Matko, Julia Manderla, Maria Bonsack, et al.
Cytometry. Part a : the Journal of the International Society for Analytical Cytology|May 26, 2017
Enumeration of WT1-specific CD8<sup>+</sup> T cells for clinical application using an MHC Streptamer based no-wash single-platform flow-cytometric assaySarah Matko, Madeleine Teichert, Antje Tunger, et al.
Immunology Letters|September 29, 2022
SARS-CoV-2-specicific humoral immunity in convalescent patients with mild COVID-19 is supported by CD4<sup>+</sup> T-cell help and negatively correlated with Alphacoronavirus-specific antibody titerMarcus Odendahl, Iris Endler, Beate Haubold, et al.
International Journal of Radiation Biology|November 10, 2009
Response of human hematopoietic stem and progenitor cells to energetic carbon ionsDaniela Becker, Thilo Elsässer, Torsten Tonn, et al.
Transfusion|September 21, 2007
Impact of leukapheresis on early death rate in adult acute myeloid leukemia presenting with hyperleukocytosisGesine Bug, Konstantinos Anargyrou, Torsten Tonn, et al.
Frontiers in Immunology|June 3, 2017
Chimeric Antigen Receptor-Engineered NK-92 Cells: An Off-the-Shelf Cellular Therapeutic for Targeted Elimination of Cancer Cells and Induction of Protective Antitumor ImmunityCongcong Zhang, Pranav Oberoi, Sarah Oelsner, et al.
Blood|August 1, 2002
Retargeting of natural killer-cell cytolytic activity to ErbB2-expressing cancer cells results in efficient and selective tumor cell destructionChristoph Uherek, Torsten Tonn, Barbara Uherek, et al.
Journal for Immunotherapy of Cancer|January 20, 2021
Inability of granule polarization by NK cells defines tumor resistance and can be overcome by CAR or ADCC mediated targetingJiri Eitler, Natalie Wotschel, Nicole Miller, et al.
Pediatric Transplantation|December 11, 2008
Intracoronary administration of autologous bone marrow-derived progenitor cells in a critically ill two-yr-old child with dilated cardiomyopathyStefan Rupp, Jürgen Bauer, Torsten Tonn, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|October 11, 2003
Sustained expansion and transgene expression of coagulation factor VIII-transduced cord blood-derived endothelial progenitor cellsChristian Herder, Torsten Tonn, Robert Oostendorp, et al.
Pageof 14